Consint.AI, a GenAI-powered healthcare insurance fraud and risk management startup, has raised Rs 5 crore in a seed funding round led by Equanimity Ventures and Seafund.
The funds will scale operations by expanding sales efforts and fast-tracking the Generative AI Feature Suite development for its Health AI Platform.
This platform includes advancements in fraud detection, streamlined claims processing, and personalized clinical care, aiming to drive innovation in healthcare.
The capital will also be used for team expansion, infrastructure enhancements, and R&D initiatives to solidify its position as a leader in health tech solutions.
Established in 2020 by Ashish Chaturvedi, with Swadeep Singh later joining as Co-Founder, Consint.AI is a trailblazer in Generative AI-powered healthcare fraud detection and risk management, committed to revolutionizing healthcare transactions and personalized care.
The company focuses on streamlining healthcare claims processing to make it more affordable and efficient through innovative platforms like Risk.ai, which enhances insurance transaction efficiency and fraud prevention, and CIPHR.ai, designed to improve critical patient management and simplify claims generation.
Leveraging advanced Generative AI technologies, Consint.AI empowers businesses in emerging markets and the U.S. to deliver value-based care, boost operational efficiency, and achieve sustainable growth.
Over the past year, Consint.AI has grown significantly, expanding its presence across India, the Middle East, and Africa. The startup recently introduced CIPHR.ai, an AI-powered platform designed specifically for hospitals, built on proprietary Generative AI models to transform personalized care in critical patient management.
CIPHR.ai delivers intelligence at the point of care and streamlines claims transactions, improving efficiency for healthcare providers. Targeted at emerging health markets and the U.S. Accountable Care Organization (ACO) sector, the platform leverages Generative AI to meet the dynamic demands of modern healthcare systems.
Consint.AI reported Rs 10 crore in signed contracts in the past two quarters, including several multi-year deals with prominent insurance providers and hospital networks. This underscores strong market validation and a growing demand for its innovative solutions, particularly in Generative AI and Document Forensics.
Ashish Chaturvedi, Founder and CEO of Consint, said, “This current market traction and milestones highlight the transformative potential of Generative AI in reshaping healthcare as we know it. At Consint, we are pioneering GenAI-driven platforms like CIPHR.ai and Risk.ai to solve complex challenges in healthcare transactions and personalized care. Our focus remains on advancing our Generative AI capabilities to drive innovation, deliver impactful solutions, and empower businesses globally to achieve seamless operations and value-based care. This funding accelerates our mission to lead the charge in AI-powered healthcare transformation.”
Manoj Agarwal, managing partner at Seafund, said, “Our focus on emerging tech like GenAI, deep tech, IoT, and sustainability has been the guiding force when it comes to backing unique and innovative startups. Consent.AI’s laser-sharp focus on solving the problem of healthcare Insurance claims processing and fraud detection, improving the performance of Insurance and Healthcare institutions is a multi-billion dollar problem to solve, and we believe that we have the necessary expertise and network to help the company grow and reach its ambitions.”
